CLEVER CULTURE SYSTEMS LIMITED — Investor Relations & Filings

Clever Culture Systems Limited specializes in the development and commercialization of automated imaging and interpretation systems for clinical microbiology. The company's flagship product, the APAS Independence, utilizes advanced artificial intelligence and machine learning algorithms to automate the screening and sorting of microbiology culture plates. By accurately identifying and removing negative plates from the workflow, the system allows laboratory staff to focus on significant clinical findings. The technology is designed to improve laboratory efficiency, standardize plate reading, and reduce turnaround times for diagnostic results. The APAS Independence is an FDA-cleared automated plate assessment system, positioning the company as a leader in the integration of AI within diagnostic pathology workflows.